Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis

Br J Haematol. 2020 Jul;190(1):e11-e13. doi: 10.1111/bjh.16792. Epub 2020 May 28.

Authors

Daniel O Griffin^{1

2}, Alexandra Jensen³, Mushmoom Khan³, Jessica Chin³, Kelly Chin³, Ryan Parnell³, Christopher Awwad³, Darshan Patel³

Affiliations

¹ Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY, USA.
² Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
³ Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

No abstract available

Keywords: COVID-19; hypercoagulability; pulmonary embolism; thromboembolic.

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / administration & dosage*
Anticoagulants / administration & dosage*
Betacoronavirus*
COVID-19
Coronavirus Infections* / complications
Coronavirus Infections* / prevention & control
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
Male
Methylprednisolone / administration & dosage*
Middle Aged
Pandemics* / prevention & control
Pneumonia, Viral* / complications
Pneumonia, Viral* / prevention & control
SARS-CoV-2
Thromboembolism* / diagnostic imaging
Thromboembolism* / drug therapy
Thromboembolism* / etiology

Substances

Antibodies, Monoclonal, Humanized
Anticoagulants
Hydroxymethylglutaryl-CoA Reductase Inhibitors
tocilizumab
Methylprednisolone